Aktiesnakken — Oktober 2012
-
nu er genmab i rødt
-
men nu trades der igennem
-
der foregår et eller andet i den
-
som jeg ikke forstår
-
tilbage i plus
-
det var måske dem der købte vildt ind op til 86
-
som partout ville af med dem igen?
-
den blev helt sikkert handlet op på misforståelsen af J&J ejerandel
-
altså fra 84 til 86,5
-
ja det tror jeg
-
handlet 127K nu
-
gsk gav 456 for sine ....
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind